Technical Analysis for GSK - GlaxoSmithKline PLC

Grade Last Price % Change Price Change
grade A 40.81 0.89% 0.36
GSK closed up 0.89 percent on Wednesday, March 20, 2019, on 70 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical GSK trend table...

Date Alert Name Type % Chg
Mar 20 Cup with Handle Other 0.00%
Mar 20 Bollinger Band Squeeze Range Contraction 0.00%
Mar 20 BB Squeeze + Upper Band Touch Range Contraction 0.00%
Mar 20 Above Upper BB Strength 0.00%
Mar 20 Upper Bollinger Band Touch Strength 0.00%
Mar 19 20 DMA Support Bullish 0.89%
Mar 19 Cup with Handle Other 0.89%
Mar 19 Bollinger Band Squeeze Range Contraction 0.89%
Mar 18 Bearish Engulfing Bearish 0.79%
Mar 18 20 DMA Support Bullish 0.79%

Older signals for GSK ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
GlaxoSmithKline plc, together with its subsidiaries, discovers, develops, manufactures, and markets pharmaceutical products, over-the-counter medicines, and health-related consumer products worldwide. It offers pharmaceutical products in various therapeutic areas comprising respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. The company provides prescription medicines to treat a range of conditions, including infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer. It also produces paediatric and adult vaccines to prevent a range of infectious diseases, including hepatitis A and B; diphtheria, tetanus, and whooping cough; measles, mumps, and rubella; polio; typhoid; influenza; and bacterial meningitis. In addition, it provides consumer health products in oral care, nutritional, total wellness, and skin health areas. The company's total wellness products include Panadol for the treatment of paracetamol-based treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; ENO Tums, a rapid relief antacid; and oral care products comprise Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to improve comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. Its nutrition products include Lucozade for energy and hydration; and Horlicks and Maxinutrition for nutrition; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. The company was founded in 1935 and is headquartered in Brentford, the United Kingdom.
Energy Medicine Health Cancer Pharmaceutical Drugs Infectious Diseases Medication Pharmaceutical Products Rare Diseases Influenza Asthma HIV Infections Depression Nutrition Products Antibiotic Wellness Products Oral Care Products Fever Smoking Cessation Eczema Glaxosmithkline Consumer Health Products Hepatitis A Joint Pain Measles Mumps Nicotine Rubella Tetanus
Is GSK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 42.36
52 Week Low 36.13
Average Volume 2,921,229
200-Day Moving Average 40.0271
50-Day Moving Average 39.8934
20-Day Moving Average 40.3825
10-Day Moving Average 40.353
Average True Range 0.4247
ADX 13.16
+DI 23.9093
-DI 15.5892
Chandelier Exit (Long, 3 ATRs ) 40.3259
Chandelier Exit (Short, 3 ATRs ) 41.0891
Upper Bollinger Band 40.7662
Lower Bollinger Band 39.9988
Percent B (%b) 1.06
BandWidth 1.900328
MACD Line 0.1482
MACD Signal Line 0.1512
MACD Histogram -0.0029
Fundamentals Value
Market Cap 99.74 Billion
Num Shares 2.44 Billion
EPS 1.03
Price-to-Earnings (P/E) Ratio 39.62
Price-to-Sales 2.27
Price-to-Book 83.56
PEG Ratio 1.10
Dividend 1.99
Dividend Yield 4.88%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 41.44
Resistance 3 (R3) 41.43 41.20 41.34
Resistance 2 (R2) 41.20 41.04 41.21 41.30
Resistance 1 (R1) 41.01 40.94 41.11 41.02 41.26
Pivot Point 40.78 40.78 40.83 40.79 40.78
Support 1 (S1) 40.59 40.62 40.69 40.60 40.36
Support 2 (S2) 40.36 40.52 40.37 40.32
Support 3 (S3) 40.17 40.36 40.29
Support 4 (S4) 40.18